These findings suggest that the PCOS model, induced by aromatase inhibitor letrozole in our research, exhibited similar endocrine and histological changes to those in human PCOS, which agreed with the results of the azole-induced PCOS model by Kafali et al. [15]. This evidence concerns the gene CYP19A1 and polycystic ovary syndrome.